A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Ramipril and losartan are equal in preventing left ventricular systolic dysfunction in ST-elevation myocardial infarction patients treated by primary percutaneous coronary intervention
2013;8(9):277. Cardiologia CROATICA Objectives: To compare the efficacy of ramipril and losartan in prevention of the left ventricular systolic dysfunction and heart failure in ST-elevation myocardial infarction (STEMI) patients treated by primary percutaneous coronary intervention (PPCI) in short (8 weeks) and long-term (six months) after acute coronary event. Patients and Methods: 55 STEMI patients (mean age 58.4 ±9.9 years, 63.6% of men) in Killip classes I-II were included; excluded weredoi:10.15836/ccar.2013.277 fatcat:gulktsow3zf4tp5c66onnfh7hm